Cargando…
Multipotent Human Mesenchymal Stromal Cells Mediate Expansion of Myeloid-Derived Suppressor Cells via Hepatocyte Growth Factor/c-Met and STAT3
Mesenchymal stromal cells (MSCs) are multilineage progenitors with immunomodulatory properties, including expansion of immunomodulatory leukocytes such as regulatory T lymphocytes (Tregs) and tolerogenic dendritic cells. We report that human MSCs can expand CD14(−)CD11b(+)CD33(+) human myeloid-deriv...
Autores principales: | Yen, B. Linju, Yen, Men-Luh, Hsu, Pei-Ju, Liu, Ko-Jiunn, Wang, Chia-Jen, Bai, Chyi-Huey, Sytwu, Huey-Kang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757753/ https://www.ncbi.nlm.nih.gov/pubmed/24052949 http://dx.doi.org/10.1016/j.stemcr.2013.06.006 |
Ejemplares similares
-
Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells
por: Chen, Pei-Min, et al.
Publicado: (2011) -
Resident vs nonresident multipotent mesenchymal stromal cell interactions with B lymphocytes result in disparate outcomes
por: Lee, Wei, et al.
Publicado: (2021) -
Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell‐free products and human pluripotent stem cell‐derived mesenchymal stem cells
por: Wang, Li‐Tzu, et al.
Publicado: (2021) -
Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID‐19
por: Yen, B. Linju, et al.
Publicado: (2020) -
Interleukin-25 Mediates Transcriptional Control of PD-L1 via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses
por: Wang, Wei-Bei, et al.
Publicado: (2015)